Correction: Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling.

Kaili Chang, Qiyuan Xie, Jianying Niu, Yong Gu, Zhonghua Zhao, Fengxia Li, Qiaojing Qin, Xueguang Liu

Open access · goldAbstract readPublished Erratum

In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.2field-weighted citation impact, top 54% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

4 · The record

Corrections and comments

Erratum for
Heparanase promotes endothelial-to-mesenchymal transition in diabetic glomerular endothelial cells through mediating ERK signaling.2022

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kaili ChangDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China.

Qiyuan XieDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China.

Jianying NiuDepartment of Nephrology, The Fifth People's Hospital, Fudan University, 801 Heqing Road, 200240, Shanghai, China.

Yong GuDepartment of Nephrology, The Fifth People's Hospital, Fudan University, 801 Heqing Road, 200240, Shanghai, China.

Zhonghua ZhaoDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China.

Fengxia LiDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China.

Qiaojing QinDepartment of Nephrology, The Fifth People's Hospital, Fudan University, 801 Heqing Road, 200240, Shanghai, China. qinqiaojing@126.com.ORCID http://orcid.org/0000-0002-4791-469X

Xueguang LiuDepartment of Pathology, School of Basic Medical Sciences, Fudan University, 131 Dongan Road, 200032, Shanghai, China. glxg69@shmu.edu.cn.ORCID http://orcid.org/0000-0002-5615-0337

Fudan University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35264558

DOI10.1038/s41420-022-00907-8

PMCPMC8907343

OpenAlexW4221099019

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.